ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 145,017 | 240,110 | 228,597 | 221,121 | 193,078 |
| Marketable Securities | 8,298 | 6,943 | 9,655 | N/A | N/A |
| Receivables | 196,361 | 166,091 | 172,418 | 162,079 | 178,842 |
| Inventories | 148,042 | 125,448 | 113,837 | 111,196 | 106,590 |
| Other current assets | 0 | 0 | 0 | 8,020 | 8,020 |
| TOTAL | $521,297 | $555,460 | $540,557 | $519,816 | $497,220 |
| Non-Current Assets | |||||
| PPE Net | 56,704 | 51,640 | 48,526 | 44,593 | 44,189 |
| Intangibles | 630,251 | 211,299 | 224,265 | 237,230 | 248,049 |
| Other Non-Current Assets | 79,125 | 102,354 | 101,176 | 102,783 | 100,456 |
| TOTAL | $766,080 | $365,293 | $373,967 | $384,606 | $392,694 |
| Total Assets | $1,287,377 | $920,753 | $914,524 | $904,422 | $889,914 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,152 | 850 | 850 | 850 | 850 |
| Accounts payable and accrued liabilities | 60,890 | 48,681 | 49,430 | 36,683 | 34,077 |
| Accrued Expenses | 120,608 | 89,606 | 74,793 | 87,514 | 74,892 |
| Other current liabilities | 1,283 | 841 | 414 | 12,266 | 23,939 |
| TOTAL | $189,933 | $139,978 | $136,889 | $145,477 | $134,352 |
| Non-Current Liabilities | |||||
| Long Term Debt | 312,918 | 284,394 | 284,607 | 284,819 | 285,032 |
| Other Non-Current Liabilities | 353,728 | 15,771 | 16,215 | 16,527 | 15,819 |
| TOTAL | $666,646 | $300,165 | $300,822 | $301,346 | $300,851 |
| Total Liabilities | $856,579 | $440,143 | $437,711 | $446,823 | $435,203 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,029 | 21,041 | 20,973 | 21,079 | 20,438 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -89,597 | -65,025 | -62,331 | -80,132 | -80,880 |
| Other shareholders' equity | 30,494 | 33,136 | 34,514 | 33,626 | 39,076 |
| TOTAL | $430,798 | $480,610 | $476,813 | $457,599 | $454,711 |
| Total Liabilities And Equity | $1,287,377 | $920,753 | $914,524 | $904,422 | $889,914 |